Key Concepts in Tumor Biology and Oncogenes

Understanding Carcinogens and Regulatory Systems

  • Carcinogens can damage DNA and increase tumor growth risk.
  • Regulatory Systems Affected by Carcinogens:
  1. Proto-Oncogenes
  2. Tumor Suppressor Genes
  3. Regulators of Apoptosis

Proto-Oncogenes and Oncogenes

  • Proto-Oncogenes: Genes essential for cell growth and differentiation.
  • Mutation leads to Oncogenes, causing unregulated cell growth.
  • Categories of Oncogenes:
  • Growth Factors
  • Growth Factor Receptors
  • Signal Transducers
  • Cell Cycle Regulators

Growth Factors and Tumors

  • Example:
  • Astrocytoma: Overexpression of Platelet Derived Growth Factor B (PDGF-B) leading to unregulated astrocyte growth.
  • Mechanism:
    • Overproduction of PDGF triggers intrinsic signaling, resulting in autocrine stimulation of tumor growth.

Growth Factor Receptors

  • HER2/neu: Amplified in some breast cancers.
  • Treatment: Targeted therapy with Trastuzumab (Herceptin).
  • RET: Associated with Medullary Carcinoma of the Thyroid (MEN 2A and 2B).
  • Clinical Note: Testing for RET mutations is crucial for prophylactic thyroidectomy.
  • KIT: Mutated in Gastrointestinal Stromal Tumors (GISTs).

Signal Transducers

  • RAS: Mutated in a wide range of cancers (70-80% of human tumors).
  • Mechanism: Mutation often affects GTPase-activating protein (GAP), preventing shut off, leading to continued signaling for growth.
  • ABL: Associated with Chronic Myelogenous Leukemia (CML) via 9:22 translocation.
  • Also relevant in Philadelphia chromosome positive Acute Lymphoblastic Leukemia (ALL).

Nuclear Regulators

  • MYC: Most important nuclear regulator.
  • Key Variants:
    • C-MYC: Associated with Burkitt's Lymphoma (translocation 8:14 prevalent).
    • N-MYC: Linked with Neuroblastoma.
    • L-MYC: Associated with Small Cell Lung Carcinoma.

Cell Cycle Regulators

  • Purpose: Proteins ensuring proper movement through the cell cycle, particularly G1 to S phase.
  • Key Regulators:
  • Cyclin D1: Linked to Mantle Cell Lymphoma (11:14 translocation facilitating overexpression).
    • Clinical Note: Expansion of mantle region in lymph nodes is characteristic.
  • CDK4: Involvement in melanoma (less emphasized but noted for completeness).

Review Key Mechanisms

  • C-MYC and B-Cell Growth:
  • Mechanism involves heavy chain loci (14) and the switch of MYC (8) due to translocation, leading to B-cell tumor proliferation.
  • Regulatory Mechanisms and Exam Tips:
  • Understanding translocations, specific gene paths, and examples help in clinical scenarios and examinations.